CCOI Myopia Workshop: Michael X. Repka, MD, MBA, on building consensus and future directions
August 27th 2025Ahead of the September 8 meeting in Paris, the program co-chair of the event and current president of the American Academy of Ophthalmology discusses how the workshop aims to shape consensus on guidelines, research priorities, and emerging therapies in myopia control.
FDA extends target action date for two Regeneron regulatory submissions to Q4 of 2025
August 21st 2025Included is the supplemental Biologics License Application (sBLA) for EYLEA HD seeking approval for both the treatment of macular edema following retinal vein occlusion (RVO) and the broadening of the dosing schedule to include every 4-week dosing across approved indications.